Reportedly, the Council of the European Union is considering member state objections and requests to extend the current scrutiny period beyond 4 December for a Commission delegated regulation that would classify titanium dioxide as a Category 2 carcinogen by inhalation. The move threatens to impact the marketing of sunscreens and other cosmetics in the EU that contain respirable TiO2 particles.
A European Commission delegated regulation classifying titanium dioxide as a Category 2 (“suspected”) carcinogen under the Classification, Labeling and Packaging (CLP) regulation is on track to apply by mid-2020.
The classification stands to impact marketers of sunscreens and other cosmetics containing respirable TiO2 particles – potentially including sunscreen sprays...
HBW Insight catches up with sustainability expert Jasper Crone to find out what consumer health companies need to know about the European Commission's Omnibus simplification package.
The European OTC market grew at double the rate of the global market in the last twelve months, according to IQVIA Consumer Health, driven by a long-term trend for prevention. Consultancy Simon Kucher identifies a desire to live a longer, healthier life as the primary concern behind this trend.
Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.
The EU Council has introduced a key amendment to Article 51 (para 1, point e) of the new pharma directive: “A medicinal product shall be subject to medical prescription where it is an antimicrobial, unless intended for topical use.”
If the European Commission is serious about improving the competitiveness of the European Union, it should ditch the idea of making commonly used OTC antimicrobials like thrush treatments and cold sore creams prescription-only, warns Greek Medicines Agency president Evangelos Manolopoulos
AESGP president Jonathan Workman opens the 61st Annual Meeting with calls for industry unity in the face of the problematic revised EU Urban Wastewater Treatment Directive.
HBW Insight speaks to NèreS' executive director Luc Besançon about the key issues facing France's self-care industry, especially Rx-to-OTC switch and the revised Urban Wastewater Treatment Directive.
